Opportunity Overview
Iowa HHS is using RFP PHTHOPD27001 to select one qualified Public Health Lead Entity in each Iowa HHS District. Each selected organization will serve as the district-level partner within the Iowa Public Health Service System during a long performance period running from January 1, 2027 through June 30, 2032.
Deadline and Key Dates
Applications are due October 8, 2026 at 12:00 PM noon local Iowa time, which is Central Daylight Time on that date. The controlling RFP expressly states that all listed dates and times are local Iowa time. Iowa HHS posted Round 1 responses on September 10. The Round 2 question deadline and mandatory Letter of Intent deadline of September 18, 2026 at 4:00 PM local Iowa time have now passed. Only applicants that timely submitted the required Letter of Intent should continue toward the October 8, 2026 at 12:00 PM noon local Iowa time application deadline; Round 2 responses and Amendment 1 were posted September 24.
Who Is Eligible
Eligible applicants are an Iowa County Board of Health or its designated Local Public Health Agency. The applicant must be located within the District for which it is applying or within a contiguous District. If the designated Local Public Health Agency submits the application, it must include a letter of attestation from its County Board of Health recognizing it as the county’s designated local public health agency. Iowa HHS intends to select the most qualified applicant in each of the seven HHS Districts.
Funding Structure
The controlling RFP anticipates up to $4,140,000 for up to seven Lead Entity awards during Phase 1, January 1, 2027 through June 30, 2028, split equally among the seven Districts, or up to $591,428 per District if all seven are awarded. For Phase 2, Iowa HHS projects $9,204,082 statewide for July 1, 2028 through June 30, 2029 and annually thereafter, with the first Phase 2 district allocations ranging from $736,014 to $2,661,728. Actual awards may increase, decrease, or be withdrawn based on funding availability and Agency decisions. The September 10 Round 1 Q&A confirms that Phase 1 uses fixed deliverable-based payments and references $331,428 and $260,000 components in the Phase 1 reimbursement chart. Iowa HHS clarifies that those payments are earned by the Lead Entity for approved Phase 1 deliverables and are not automatically divided among counties or local providers. Phase 2 uses Agency-approved line-item budgets and reimbursement, with district funding allocations varying by the applicable funding sources and approved plan. Applicants should therefore use the controlling RFP and contracts rather than infer a single full-contract ceiling from the storefront.
September 10 Q&A Update
Iowa HHS posted Round 1 responses on September 10, 2026. The answers clarify that HHS retains final authority over district funding while each Lead Entity administers an HHS-approved annual line-item budget. Lead Entities generally follow their own governing procurement policies plus applicable state and federal rules, with HHS retaining subcontract review and approval authority. The answers also clarify that provider capacity includes workforce, infrastructure, systems and data-reporting readiness, but HHS does not prescribe a single statewide software platform and will provide access, training and guidance for required Agency-supported reporting systems.
Strategic Value
Atlas Opportunity Score: 88/100. This is a high-value statewide public-health systems opportunity because selected Lead Entities will sit at the center of district-level coordination, planning, accountability and service-system integration for more than five years.
N9+ Direct Vendor Fit: conditional and not yet established as an allowable direct cost. The September 10 answers strengthen a possible downstream subcontractor or technology-partner pathway because Lead Entities may use approved subcontracts and capacity planning expressly includes infrastructure and systems. However, Iowa HHS did not affirm that proposed software purchases or integration fees are allowable Phase 1 direct costs, and it will provide the Agency-supported reporting systems required for district reporting. N9+ should therefore be positioned only where an applicant identifies a separate, legitimate clinical or public-health use case and the controlling contract, budget and procurement rules support the cost.
Round 1 Q&A Clarifications
Iowa HHS retains final authority over district funding and has not established a predetermined allocation formula or minimum payment to local providers. Counties and local public health agencies retain authority over their county service-delivery model; a Lead Entity may not override that model or provide services in a county without agreement.
The Round 1 answers also clarify that anti-supplanting rules prohibit replacing existing funded duties, but genuinely new, expanded or transferred Lead Entity responsibilities may be supported, including documented reallocations of salary percentages. Lead Entities follow their own governing procurement policies together with applicable state and federal requirements, while HHS reviews subcontracts of $5,000 or more. The applicant must include a support letter from its own Board of Health, and the Project Director should be directly employed by the Lead Entity, although support functions may be subcontracted.
Lead Entities remain accountable for subcontractor performance and should use enforceable subcontract protections. Iowa HHS did not affirm software or technology allowability in its response to the related system-integration question, so technology concepts, including N9+, remain downstream and conditional unless a specific allowable-cost and procurement pathway is verified.
Additional Round 1 controls materially reduce applicant-side risk: Lead Entities are not required to contribute county, local or other non-HHS funds if Phase 2 resources are insufficient; unused Phase 2 funds do not carry forward automatically and depend on the rules of the underlying federal or state funding source; and legal or specialized consulting costs are not affirmatively allowable yet and will be resolved during Phase 2 contract negotiations. The current draft language also allows a Lead Entity to exit only for an uncured material breach by the State.
Application Strategy
Eligible Iowa County Boards of Health and designated Local Public Health Agencies should review the full RFP, Iowa HHS District Map, work-plan formatting specifications, both draft contracts, the September 10 Round 1 responses and IowaGrants submission guidance. The mandatory Letter of Intent deadline of September 18, 2026 at 4:00 PM local Iowa time has passed. Applicants should proceed only if they timely submitted the required Letter of Intent. Round 2 responses and Amendment 1 were posted September 24, and the complete application remains due October 8, 2026 at 12:00 PM noon local Iowa time.
Verified source: IowaGrants opportunity 684057 and the controlling RFP PHTHOPD27001, rechecked September 19, 2026. The RFP confirms applicant eligibility, Phase 1 and Phase 2 funding structure, and that all listed deadlines use local Iowa time.